# Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions

> **NCT00002872** · PHASE3 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 480 (estimated)

## Conditions studied

- Metastatic Cancer

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **DRUG:** doxycycline
- **OTHER:** talc

## Key facts

- **NCT ID:** NCT00002872
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-01-10
- **Primary completion:** 2003-02
- **Final completion:** —
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002872, "Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00002872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*